Related references
Note: Only part of the references are listed.The outcome of COVID-19 in patients with hematological malignancy
Tugce N. Yigenoglu et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study
Ahmed Yousaf et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study
Nathanael R. Fillmore et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
COVID-19 and myeloproliferative neoplasms: some considerations
Baransel Kamaz et al.
LEUKEMIA (2021)
Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland
Aron Hjalti Bjornsson et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection
QuanQiu Wang et al.
JAMA ONCOLOGY (2021)
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm
Richard A. Salisbury et al.
LEUKEMIA (2021)
Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis
Zhixian Lin et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2021)
COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway
Tom Borge Johannesen et al.
FRONTIERS IN ONCOLOGY (2021)
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
P. Grivas et al.
ANNALS OF ONCOLOGY (2021)
Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan's experience
Abdul Waris et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)
Noha Sharafeldin et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
The influence of selection bias on identifying an association between allergy medication use and SARS-CoV-2 infection
Lindsay A. Thompson et al.
ECLINICALMEDICINE (2021)
Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid
J. Rogado et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019-United States, February 12-March 28, 2020
Nancy Chow et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Francesco Passamonti et al.
LANCET HAEMATOLOGY (2020)
Coagulopathy in COVID-19
Toshiaki Iba et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
COVID-19 among fit patients with CLL treated with venetoclax-based combinations
Moritz Fuerstenau et al.
LEUKEMIA (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19
Emre Yekeduz et al.
EUROPEAN JOURNAL OF CANCER (2020)
Thrombosis risk associated with COVID-19 infection. A scoping review
Fatimah Al-Ani et al.
THROMBOSIS RESEARCH (2020)
Chemotherapy and COVID-19 Outcomes in Patients With Cancer
Justin Jee et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
Julio Garcia-Suarez et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
Stephanie L. Harrison et al.
PLOS MEDICINE (2020)
Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, Italy
Alexia Francesca Bertuzzi et al.
CANCERS (2020)
Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study
Jing Gong et al.
BMC INFECTIOUS DISEASES (2020)
Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis
Shirley Sze et al.
ECLINICALMEDICINE (2020)
Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data
Vassilis G. Giannakoulis et al.
JCO GLOBAL ONCOLOGY (2020)
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)
M. Reinwald et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Adjust for Multiple Comparisons? It's Not That Simple
Andrew D. Althouse
ANNALS OF THORACIC SURGERY (2016)
Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation
Sylvie Hermouet et al.
MEDIATORS OF INFLAMMATION (2015)
mice: Multivariate Imputation by Chained Equations inR
Stef van Buuren et al.
Journal of Statistical Software (2015)
Myeloproliferative disorders: complications, survival and causes of death
S Brodmann et al.
ANNALS OF HEMATOLOGY (2000)